RXi Pharmaceuticals announces positive results with RXI-231 in consumer testing program
RXi Pharmaceuticals Corporation, a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, announced the results of a consumer/functional testing program with RXI-231, a...
Read More